Medicinal Genomics CSO and Founder Kevin McKernan addresses concerns that have been raised about testing cannabis samples for yeast and mold contamination. The presentation covers several myths and misunderstandings surrounding the enumeration of yeast and mold, Including:
Topics Include:
©2024 MEDICINAL GENOMICS CORPS
Copyright all right reserved.
Signup to receive email updates on blog posts, podcasts, webinars, new products, and more!
Join us at the CannMed 24 Innovation and Investment Summit, an exclusive experience of discovery, development, and networking with innovators from around the world.